Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus.

Artz, Marika A

Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus. [electronic resource] - Journal of the American Society of Nephrology : JASN Jul 2003 - 1880-8 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1046-6673

10.1097/01.asn.0000071515.27754.67 doi


Adult
Aged
Analysis of Variance
Apolipoproteins B--blood
Blood Glucose--metabolism
Blood Pressure
Body Weight
Cardiovascular System--drug effects
Cholesterol--metabolism
Cyclosporine--therapeutic use
Female
Fibrinogen--metabolism
Fibrinolysis
Graft Survival
Humans
Immunosuppressive Agents--therapeutic use
Kidney--drug effects
Kidney Transplantation
Lipoproteins, LDL--metabolism
Male
Middle Aged
Oxygen--metabolism
Risk Factors
Tacrolimus--therapeutic use
Time Factors
Triglycerides--blood